Cargando…

Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study

BACKGROUND: Type 2 diabetes mellitus (T2DM) and thyroid disorders are common endocrine disorders. This case–control study aims to determine the prevalence and predictors of thyroid disorders in T2DM patients. METHODS: A total of 998 T2DM patients attending a tertiary hospital were included and under...

Descripción completa

Detalles Bibliográficos
Autores principales: Khassawneh, Adi H, Al-Mistarehi, Abdel-Hameed, Zein Alaabdin, Anas M, Khasawneh, Laith, AlQuran, Thekraiat M, Kheirallah, Khalid A, Saadeh, Nesreen A, Beni yonis, Othman, Shawkat, Mohamid, Obeidat, Nail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568427/
https://www.ncbi.nlm.nih.gov/pubmed/33116772
http://dx.doi.org/10.2147/IJGM.S273900
_version_ 1783596517096947712
author Khassawneh, Adi H
Al-Mistarehi, Abdel-Hameed
Zein Alaabdin, Anas M
Khasawneh, Laith
AlQuran, Thekraiat M
Kheirallah, Khalid A
Saadeh, Nesreen A
Beni yonis, Othman
Shawkat, Mohamid
Obeidat, Nail
author_facet Khassawneh, Adi H
Al-Mistarehi, Abdel-Hameed
Zein Alaabdin, Anas M
Khasawneh, Laith
AlQuran, Thekraiat M
Kheirallah, Khalid A
Saadeh, Nesreen A
Beni yonis, Othman
Shawkat, Mohamid
Obeidat, Nail
author_sort Khassawneh, Adi H
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus (T2DM) and thyroid disorders are common endocrine disorders. This case–control study aims to determine the prevalence and predictors of thyroid disorders in T2DM patients. METHODS: A total of 998 T2DM patients attending a tertiary hospital were included and underwent investigations for thyroid function: thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3); and glycated hemoglobin (HbA1c). They were compared with 343 non-diabetic subjects as controls. RESULTS: A total of 1341 participants were included in the study. The mean age ± SD was 60.14 ± 12.21, and 47.9% were females. Among T2DM patients, 140 (14%) were known to have thyroid disorders; and as a direct result of screening, 126 (12.6%) new cases of thyroid disorder were diagnosed. Thus, the overall prevalence of thyroid disorders was found to be 26.7% in T2DM patients which significantly higher than the controls (13.7%), (p˂0.001). Subclinical hypothyroidism was the most common one. Using logistic regression, after adjusting for age, gender, obesity, smoking, anemia, presence of goiter, disease duration, and poorly controlled, the risk factors for thyroid dysfunction among T2DM patients were an age of ≥50 years with an adjusted OR of 3.895 (95% CI 2.151–7.052, p<0.001); female gender (OR 1.757, 95% CI 1.123–2.747, p=0.013); goiter (OR 2.904, 95% CI 1.118–7.547, p=0.029), and HbA1c>7% (OR 2.553, 95% CI 1.472–4.429, p=0.001). However, there were no significant associations between thyroid disorders and complications or duration of diabetes (p>0.050). CONCLUSION: A high prevalence of thyroid disorders was reported in T2DM patients. Therefore, we suggest that diabetic patients should be routinely screened for thyroid dysfunction. Old age, female gender, goiter, and poorly controlled diabetes found to be risk factors for thyroid dysfunction among T2DM patients. Consequently, appropriate management and control of diabetes may lower the risk of thyroid dysfunction and vice versa.
format Online
Article
Text
id pubmed-7568427
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75684272020-10-27 Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study Khassawneh, Adi H Al-Mistarehi, Abdel-Hameed Zein Alaabdin, Anas M Khasawneh, Laith AlQuran, Thekraiat M Kheirallah, Khalid A Saadeh, Nesreen A Beni yonis, Othman Shawkat, Mohamid Obeidat, Nail Int J Gen Med Original Research BACKGROUND: Type 2 diabetes mellitus (T2DM) and thyroid disorders are common endocrine disorders. This case–control study aims to determine the prevalence and predictors of thyroid disorders in T2DM patients. METHODS: A total of 998 T2DM patients attending a tertiary hospital were included and underwent investigations for thyroid function: thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3); and glycated hemoglobin (HbA1c). They were compared with 343 non-diabetic subjects as controls. RESULTS: A total of 1341 participants were included in the study. The mean age ± SD was 60.14 ± 12.21, and 47.9% were females. Among T2DM patients, 140 (14%) were known to have thyroid disorders; and as a direct result of screening, 126 (12.6%) new cases of thyroid disorder were diagnosed. Thus, the overall prevalence of thyroid disorders was found to be 26.7% in T2DM patients which significantly higher than the controls (13.7%), (p˂0.001). Subclinical hypothyroidism was the most common one. Using logistic regression, after adjusting for age, gender, obesity, smoking, anemia, presence of goiter, disease duration, and poorly controlled, the risk factors for thyroid dysfunction among T2DM patients were an age of ≥50 years with an adjusted OR of 3.895 (95% CI 2.151–7.052, p<0.001); female gender (OR 1.757, 95% CI 1.123–2.747, p=0.013); goiter (OR 2.904, 95% CI 1.118–7.547, p=0.029), and HbA1c>7% (OR 2.553, 95% CI 1.472–4.429, p=0.001). However, there were no significant associations between thyroid disorders and complications or duration of diabetes (p>0.050). CONCLUSION: A high prevalence of thyroid disorders was reported in T2DM patients. Therefore, we suggest that diabetic patients should be routinely screened for thyroid dysfunction. Old age, female gender, goiter, and poorly controlled diabetes found to be risk factors for thyroid dysfunction among T2DM patients. Consequently, appropriate management and control of diabetes may lower the risk of thyroid dysfunction and vice versa. Dove 2020-10-12 /pmc/articles/PMC7568427/ /pubmed/33116772 http://dx.doi.org/10.2147/IJGM.S273900 Text en © 2020 Khassawneh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Khassawneh, Adi H
Al-Mistarehi, Abdel-Hameed
Zein Alaabdin, Anas M
Khasawneh, Laith
AlQuran, Thekraiat M
Kheirallah, Khalid A
Saadeh, Nesreen A
Beni yonis, Othman
Shawkat, Mohamid
Obeidat, Nail
Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title_full Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title_fullStr Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title_full_unstemmed Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title_short Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study
title_sort prevalence and predictors of thyroid dysfunction among type 2 diabetic patients: a case–control study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568427/
https://www.ncbi.nlm.nih.gov/pubmed/33116772
http://dx.doi.org/10.2147/IJGM.S273900
work_keys_str_mv AT khassawnehadih prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT almistarehiabdelhameed prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT zeinalaabdinanasm prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT khasawnehlaith prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT alquranthekraiatm prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT kheirallahkhalida prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT saadehnesreena prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT beniyonisothman prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT shawkatmohamid prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy
AT obeidatnail prevalenceandpredictorsofthyroiddysfunctionamongtype2diabeticpatientsacasecontrolstudy